GlassScriptPhysician profile
Corey W Harp
NPI 1659843712
$2,067.14
in general payments reported to CMS, 2019-2025
8 companies · $17.09 in 2025
The $17.09 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2023: $179 · 2024: $1,751 · 2025: $17.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,445 · Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,444.95 |
| Food and Beverage | $502.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $1,291.11 | 2024 | |
| Arthrex, INC. | $459.90 | 2024 | |
| Stryker Corporation | $122.13 | 2023 | Mako, Restoration |
| Active Medical, LLC | $60.45 | 2021 | |
| Djo, LLC | $56.98 | 2023 | Cmf, Procare, Aircast |
| Smith+Nephew, INC. | $38.18 | 2021 | |
| Vericel Corporation | $21.30 | 2021 | |
| Abbott Laboratories | $17.09 | 2025 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Harp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.